Psychemedics Corporation / Fundamentals
Income statement
- Net revenue
€16.89M - Cost of goods sold
€10.80M - Gross profit
€6.09M - SG&A expenses
€7.07M - R&D expenses
€642.64K - EBITDA
-€229.09K - D&A
€1.40M - EBIT
-€1.62M - Interest expenses
€0.00 - EBT
-€1.64M - Tax expenses
-€47.19K - Net income
-€1.60M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€580.01K - Changes in working capital
€280.57K - Operating cash flow
€797.08K - Capex
€48.05K - Other investing cash flow
-€30.89K - Net investing cash flow
-€74.65K - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
-€678.68K - Other financing cash flow
€26.60K - Net financing cash flow
-€1.19M - Foreign exchange effects
€0.00 - Net change in cash
-€469.33K - Cash at end of period
€1.22M - Free cash flow
€845.13K
Balance sheet
- Cash and cash equivalents
€1.22M - Cash and short-term investments
€1.22M - Total receivables
€2.17M - Inventory
€0.00 - Other current assets
€855.43K - Total current assets
€4.24M - Property, plant & equipment
€2.51M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€390.39K - Total non-current assets
€2.90M - Total assets
€7.14M - Accounts payable
€396.40K - Short-term debt
€591.16K - Other current liabilities
€1.32M - Total current liabilities
€2.33M - Long-term debt
€409.27K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€409.27K - Total liabilities
€2.74M - Common stock
€28.31K - Retained earnings
-€15.99M - Other equity
-€1.40M - Total equity
€4.40M - Total liabilities and shareholders' equity
€7.14M
Company information
- Market capitalization
€13.42M - Employees
116 - Enterprise Value
€15.49M
Company ratios
- Gross margin
-
36.1% Much better than peer group: 15.2% - EBITDA margin
-
-1.4% Much better than peer group: -1,925.6% - EBIT margin
-
-9.6% Much better than peer group: -2,065.8% - EBT margin
-
-9.7% Much better than peer group: -2,048.9% - Net margin
-
-9.5% Much better than peer group: -2,043.7% - ROE
-
-36.3% Much worse than peer group: 35.7% - ROA
-
-22.4% Better than peer group: -33.9% - Asset turnover
-
236.7% Much better than peer group: 51.2% - FCF margin
-
4.4% Much better than peer group: -1,664.2% - FCF yield
5.6% - Efficiency ratio
101.4% - Net sales per employee
-
€145.60K - Net income per employee
-
-€13.76K